CoreWeave vs Fivetran: employee equity compared
Secondary market prices, valuation trajectory, equity structure, and liquidity outlook for employees choosing between CoreWeave and Fivetran.
CoreWeave
Specialised GPU cloud provider purpose-built for AI/ML training and inference — 45,000+ NVIDIA H100s available on-demand.
IPO plausible 2027–2029 if growth trajectory holds. Liquidity may come via tender offer or strategic acquisition before listing.
Sticky enterprise ARR; RSU (no exercise cost); IPO imminent when ARR > $1B
Fivetran
Automated ELT pipeline platform with 500+ pre-built connectors that replicate data from any SaaS, database, or event source into cloud warehouses.
IPO possible 2027–2029 once ARR milestones are hit. Secondary trades at a discount vs last round — exercise timing requires caution. Strategic M&A also plausible in consolidating sector.
Sticky enterprise ARR; ISO/NSO options; secondary discount vs primary — price discovery ongoing; IPO imminent when ARR > $1B
Key differences for employees
Equity structure
CoreWeave grants RSU — no exercise cost. Your equity vests and converts to cash or shares automatically at a liquidity event. Fivetran grants ISO/NSO with strike prices from $18–$30.
Secondary market premium
The secondary market is pricing CoreWeave at a +3% premium over its last primary round ($19B → $19.6B). Fivetran trades at +-14% over its last round ($5.6B → $4.8B). A higher secondary premium signals stronger investor demand and potentially better near-term liquidity for employees looking to sell.
Revenue and growth
CoreWeave runs at $2B ARR, growing +150% YoY (very fast). Fivetran runs at $0.2B ARR, growing +35% YoY (solid). Revenue growth rate matters for equity because it drives the peer-multiple valuation — the method most correlated with exit multiples.
Liquidity timeline
CoreWeave: IPO plausible 2027–2029 if growth trajectory holds. Liquidity may come via tender offer or strategic acquisition before listing.
Fivetran: IPO possible 2027–2029 once ARR milestones are hit. Secondary trades at a discount vs last round — exercise timing requires caution. Strategic M&A also plausible in consolidating sector.
Calculate your specific grant
Enter your actual shares, equity type, and strike price. PrivatePulse calculates your personal equity value at both companies using 4 independent methods.